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1 Introduction
1.1 Energy homeostasis
Energy homeostasis is in balance when energy intake (ingestion and absorption of 
calories) equals energy output (energy expenditure). Therefore food intake and energy 
expenditure play critical roles in the maintenance of energy balance. Body mass and 
composition reflect the collective effects of three processes of energy homeostasis: energy 
intake, energy storage, and energy expenditure. Excessive energy intake results in storage of 
energy in fat depots leading to increased body weight and body adiposity.
The central nervous system (CNS) monitors the energy status of the body (energy 
stores, energy intake and energy expenditure) and modulates both food intake and energy 
expenditure. This negative feedback control operates to maintain body fat stores more or less
constant over long periods of time. The CNS receives inputs from several different signals 
such as metabolic, neural and endocrine factors.
The control of food intake in humans and animals is a complex and fine-tuned
interaction between different hormones, gastrointestinal stimuli, and neurotransmitters. Both 
peripheral and central feedback signals are processed in the CNS and result in increased food 
intake (“hunger”) or decreased food intake (“satiation”). A number of parameters are involved 
in the feedback control of an ongoing meal, among others vision, smell, or taste (Woods, 
Benoit et al. 2004). These signals are counteracted by signals arising from the stomach and 
intestine, as e.g. demonstrated in sham feeding experiments with gastric fistula (Davis and 
Campbell 1973).
Interaction of food with the stomach and intestine elicits the secretion of different gut 
peptides and other signals which coordinate and optimize the digestive processes.
Interestingly, most of these signals also seem to be involved in the control of eating. The first 
discovered satiation signal is the gut peptide cholecystokinin (CCK) (Gibbs, Young et al. 
1973). The size of a meal is dose-dependently reduced after administration of CCK prior to 
that meal. In addition to CCK, there are other satiation signals which inform the brain 
precisely about what has been ingested, e.g. gastrin releasing peptide (Stein and Woods 
1982), somatostatin (Lotter, Krinsky et al. 1981), glucagon-like peptide-1 (Naslund, 
Barkeling et al. 1999), apolipoprotein A-IV (Fujimoto, Machidori et al. 1993) and peptide YY 
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(Batterham, Cowley et al. 2002). All these peptides secreted from the gastrointestinal system 
have been reported to reduce meal size when administered systemically. In addition to these 
gastrointestinal peptides, the hormones amylin (Chance, Balasubramaniam et al. 1991; Lutz, 
Del Prete et al. 1994) and glucagon (Woods, Lutz et al. 2006) secreted from the pancreatic 
islets during meals, are considered to have similar characteristics.
The mechanism of action by which each of these peptides signals to the CNS and 
contributes to the phenomenon of satiation may be different. Some are thought either to 
activate receptors on vagal afferent fibers projecting to the hindbrain, e.g. CCK (Lorenz and 
Goldman 1982; Davison and Clarke 1988) and glucagon (Geary, Le Sauter et al. 1993; 
Langhans 1996) or else to stimulate the hindbrain directly at sites with an open blood-brain 
barrier (BBB) such as amylin acting on the area postrema (Lutz, Del Prete et al. 1995; Lutz, 
Senn et al. 1998).
The hormones insulin and leptin are considered as important adiposity signals 
(Schwartz 1997; Woods, Seeley et al. 1998; Schwartz, Woods et al. 2000). Both hormones 
circulate at levels proportional to body fat content (Bagdade, Bierman et al. 1967; Considine, 
Sinha et al. 1996), hence reflecting the size of the body adipose tissue. They enter the CNS in 
proportion to their plasma level (Baura, Foster et al. 1993; Schwartz, Peskind et al. 1996).
Genetically obese mice (ob/ob mouse) have been suggested to lack a circulating factor
(Ingalls, Dickie et al. 1950). This factor was discovered much later as the gene product of the 
ob gene and was named leptin (Zhang, Proenca et al. 1994). It is secreted by adipocytes into 
the bloodstream and reaches the brain, where it influences specific hypothalamic pathways 
resulting in a reduction in food intake and an increase in energy expenditure. The central 
target site of leptin is supposed to be the arcuate nucleus (ARH) located in the hypothalamus, 
where leptin inhibits the release of the orexigenic neuropetide Y and agouti-related protein
(Mercer, Hoggard et al. 1996; Guan, Hess et al. 1997; Baskin, Hahn et al. 1999). Leptin also 
activates proopiomelanocortin neurons to increase the production and release of the 
anorexigenic hormone -MSH.
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1.2 Amylin
1.2.1 Structure and occurrence
Eugene Opie described in 1901 the occurrence of “hyaline degeneration of the islands 
of Langerhans” in patients with hyperglycaemia (Opie 1901). He found that the secreting 
tissue of the gland is destroyed for the most part and is replaced by fibrous dense tissue as a 
homogeneous material within every islet. This was the first description of islet amyloid. In the 
middle of the 1980’s the major component of these amyloid deposits confined to the islets of 
Langerhans was isolated, sequenced and termed islet amyloid polypeptide (IAPP) and later
amylin (Westermark, Wernstedt et al. 1986; Cooper, Willis et al. 1987; Westermark, 
Wernstedt et al. 1987b; Westermark, Wilander et al. 1987c; Leighton and Cooper 1988).
Amylin is now known to be also a physiologically important circulating hormone. It is a 37-
amino-acid peptide and is mainly produced in the -cells of islets of Langerhans in the 
pancreas (Denijn, De Weger et al. 1992). It is stored in the same secretory granules as insulin 
(Westermark, Wernstedt et al. 1987a; Westermark, Wernstedt et al. 1987b; Johnson, O'Brien 
et al. 1988). The co-secretion of amylin from the -cells together with insulin is induced by 
nutrient stimuli, e.g. before and during food intake or due to the increase of blood glucose 
levels (Lukinius, Wilander et al. 1989; Butler, Chou et al. 1990; Moore and Cooper 1991).
The ratio of amylin : insulin release ranges between 1-5 : 100 under physiological conditions.
The level of the postprandial amylin concentration in the blood depends on the amount of 
food eaten (Butler, Chou et al. 1990). Apart from the -cells as the main production site, 
amylin is also synthesized in lower concentrations in other tissues, namely in the 
gastrointestinal tract (especially in the antrum pyloricum and colon), in the lung, and in 
certain parts of the nerve tissue (e.g. spinal ganglia) (Ferrier, Pierson et al. 1989; Asai, 
Nakazato et al. 1990; Nicholl, Bhatavdekar et al. 1992).
Amylin belongs to the calcitonin gene peptide superfamily consisting of calcitonin 
(CT), calcitonin gene-related peptide (CGRP), adrenomedullin and has major sequence 
homology with CGRP. All these peptides are derived from a precursor protein expressed by
the CALC1 gene. Aside from the structural homology, they exert similar biological effects 
and have similar components of receptors (Wimalawansa 1997).
The specificity of the receptors is modulated by so-called receptor activity modifying proteins 
(RAMP’s) that are co-expressed with the calcitonin receptor (CTR). Co-expression of the 
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CTR with RAMP1 or RAMP3 leads to a specific amylin receptor (Christopoulos, Perry et al. 
1999; Foord and Marshall 1999; Muff, Buhlmann et al. 1999; Sexton, Albiston et al. 2001).
1.2.2 Effects
1.2.2.1 Effects of amylin on nutrient fluxes
In today’s view, effects of amylin on nutrient flux complement those of insulin.
Amylin controls the nutrient flux from the ingested diet to the blood stream while insulin 
modulates more the utilisation of nutrients (mainly glucose) out of this reservoir. The best 
investigated functions of amylin to control nutrient fluxes are its effects to inhibit glucagon 
secretion and gastric emptying (Fig. 1.)
The prandial glucagon secretion from pancreatic -cells is inhibited by insulin. 
Gedulin, Rink et al. (1997) showed that amylin also inhibits -cell secretion of glucagon in
response to infused amino acids (L-arginine). Amylin administration dose-dependently 
suppressed the glucagon response to arginine. The suppression of postprandial glucagon 
secretion leads to decreased hepatic glucose release (Weyer, Maggs et al. 2001).
A further effect of amylin is an inhibition of gastric emptying that delays the transport
of ingesta from the stomach to the small intestine without affecting small bowel or colonic 
transit (Young, Gedulin et al. 1996; Samsom, Szarka et al. 2000). This suppression of vagus-
mediated regulation of gastric emptying was also reported by Weyer, Maggs et al. (2001) as 
an indirect regulation of glucose absorption (Weyer, Maggs et al. 2001), thereby helping to 
control the influx of endogenous and exogenous glucose, respectively. Additionally, amylin 
exerts a gastric-protecting effect by an inhibition of both gastric motility (Clementi, Caruso et 
al. 1996; Kong, King et al. 1997) and secretion of gastric acid.
1.2.2.2 Effects on food intake
Amylin plays a physiological role in the control of eating (Fig. 1.). Its suppressive
effect on eating has been demonstrated after peripheral (Chance, Balasubramaniam et al. 
1993; Lutz, Del Prete et al. 1994; Morley, Flood et al. 1994; Lutz, Geary et al. 1995) or 
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central (Balasubramaniam, Renugopalakrishnan et al. 1991; Chance, Balasubramaniam et al. 
1991; Chance, Balasubramaniam et al. 1992; Lutz, Rossi et al. 1998c) administration. 
Amylin’s anorectic effect is mainly caused by a reduction in size and duration of the first 
meal after acute administration (Lutz, Geary et al. 1995) suggesting that amylin inhibits 
feeding by a meal-ending satiation processes. Similar findings, i.e. that amylin decreases 
eating mainly by a meal size effect, were obtained after chronic amylin infusion at low doses
(Arnelo, Permert et al. 1997; Lutz, Mollet et al. 2001a). The anorectic effect of amylin is 
considered specific because neither a peripheral nor a central administration of amylin reduce 
food intake by producing a conditioned taste aversion (Chance, Balasubramaniam et al. 1992; 
Lutz, Geary et al. 1995; Rushing, Seeley et al. 2002).
To investigate whether amylin acts in the periphery or has a central site of action, 
experiments were performed using rats with lesioned afferent nerve fibres because abdominal 
vagal and splanchnic afferents play an important role in the control of food intake by
transmission of various signals to the central nervous system. Interestingly, the anorectic 
effect of amylin was not blocked in animals with a dissection of the common hepatic vagus 
branch (Lutz, Del Prete et al. 1994) or a destruction of primary sensory (vagal and splanchnic) 
afferents caused by an intraperitoneal (IP) administration of the neurotoxin capsaicin (Lutz, 
Althaus et al. 1998b). Hence, contrary to CCK (Joyner, Smith et al. 1993), the anorectic effect 
of peripherally administered amylin does not depend on an intact abdominal vagus (Lutz, 
Althaus et al. 1998b). These findings suggest a central site of amylin’s action (Morley, Flood 
et al. 1994; Lutz, Del Prete et al. 1995).
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Fig. 1. Effects of amylin (adapted from A. Young, 2005). Amylin is 
secreted in response to nutrients. The nutrient entry into the circulation is 
controlled by amylin-mediated inhibition of food intake, nutrient digestion, 
nutrient transit, and hepatic glucose production (glucagon). All these amylin 
effects complement the actions of insulin which accelerates nutrient disposal 
and storage.
There are several indications that amylin may also act as an adiposity signal like leptin 
and insulin. Interestingly, recent studies showed synergistic effects of amylin and leptin in 
leptin-resistant, diet-induced obese rats in which amylin agonists restore leptin responsiveness 
(Roth, Roland et al. 2008). Furthermore the weight loss synergy was specific to amylin 
treatment, compared with other anorexigenic peptides (e.g. peptide YY or glucagon-like 
peptide-1). Addition of leptin after 14d amylin pretreatment caused further weight loss,
compared to amylin or leptin monotherapy. A long term clinical study in overweight/obese 
subjects also demonstrated a greater weight loss of co-administration of recombinant human 
leptin and the amylin analogue pramlintide compared to either treatment alone (Roth, Roland 
et al. 2008).
These findings provide both nonclinical and clinical evidence that amylin agonism 
restores leptin responsiveness in diet-induced obesity. Based on these findings amylin is 
Stomach
Pancreas
Liver
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currently under investigation as a promising pharmacotherapeutical approach to treat obesity 
and diabetes (Edelman, Maier et al. 2008; Kesty, Roth et al. 2008).
1.3 Area postrema
The actions of amylin on food intake, glucagon secretion and gastric emptying are 
mediated by the area postrema (AP) a brain structure located in the medulla oblongata (Lutz 
2005). The AP as a main site of amylin’s effect has some particular properties and is 
connected to other brain areas which are involved in regulation of food intake and energy 
homeostasis.
1.3.1 Morphology and function
The AP belongs to the so-called circumventricular organs (CVO’s) located around the 
ventricular system. The CVO’s have common morphological and functional characteristics 
that differentiate them from the rest of the nervous system. A specific property are cellular 
contacts with two fluid compartments, blood and cerebrospinal fluid (Johnson and Gross 
1993). In mammals, there are different CVO’s such as the subfornical organ (SFO), organum 
vasculosum of the lamina terminalis (OVLT), median eminence, subcommissural organ, 
pineal gland, posterior pituitary, and the AP. Some of them namely the AP, SFO, and the 
OVLT are supposed to be targets for blood-borne information, e.g. hormones, reaching the 
brain this way.
Most CVO’s are densely vascularized and have a permeable capillary network that 
allows secretion or tissue penetration by different circulating substances. This differentiates 
the CVO’s from other CNS structures where the permeability of the BBB is limited by the 
microvascular characteristics of the capillary endothelium (Gross 1992).
The AP, with its v-shaped appearance, is situated on the dorsal surface of the medulla
oblongata adjacent to the nucleus of the solitary tract (NTS) and located at the caudal end of 
the fourth ventricle. It was one of the first recognized structures of the CVO’s with a lacking 
BBB where circulating substances have direct access to neurons via the fenestrated
capillaries. One of the first functions described for the AP was its role as “chemoreceptor 
trigger zone” (Borison 1974; Carpenter 1990) provoking emesis as a protection reflex that 
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allows an individual to rid itself of ingested toxins or poisons. Studies using animals with 
lesions in the AP demonstrated that the AP is involved in developing a conditioned taste 
aversion e.g. due to the treatment with different aversive stimuli (Ritter, McGlone et al. 
1980).
The AP plays an important role in the control of feeding behaviour (Fry and Ferguson 
2007) as also demonstrated in AP lesioned animals (Edwards and Ritter 1981; Hyde and 
Miselis 1983). In the context of the present study, it is important to note that the AP was 
identified as primary receptive target area for amylin. Binding sites with high affinity for 
amylin have been discovered in different brain structures, but particularly the AP contains a
high density of amylin receptors (Bhogal, Smith et al. 1992; Beaumont, Kenney et al. 1993; 
Sexton, Paxinos et al. 1994; Christopoulos, Paxinos et al. 1995). After a thermal ablation of 
the AP/NTS, the anorectic effect of IP injected amylin (5 microg/kg) was significantly 
reduced in food deprived rats (Lutz, Senn et al. 1998a). Furthermore, infusion of various 
doses of amylin with chronic cannulas aiming at the AP inhibited food intake for about 2h
after food presentation. Infusion of the amylin antagonist AC187 into the AP reduced the 
anorectic effect induced by an IP injection of amylin, and AC187 alone increased food intake 
when administered into the AP.
An action of amylin on AP neurons was also characterized by the detection of c-Fos 
expression. c-Fos is an immediate early gene product that is used as an experimental marker 
of neuronal cell activation. The expression of c-Fos is induced by activation of neurons
following specific stimuli and is assessed by immunohistochemical techniques (Hoffman, 
Smith et al. 1993). In several studies Fos-like immunoreactivity was used to investigate the 
amylin-mediated activation of neurons e.g. in the AP (Rowland, Crews et al. 1997; Riediger, 
Schmid et al. 2001). Peripheral administration of amylin induced c-Fos expression in the AP, 
the nucleus of the solitary tract, the bed nucleus of the stria terminalis (BST) and the central 
nucleus of the amygdala (CeA). Further evidence for an activation of AP neurons was 
provided by electrophysiological studies with in vitro slice preparations of the rat AP. Amylin 
induced dose-dependent excitatory responses in these neurons, which could be antagonized by 
the amylin receptor blocker AC187 (Riediger, Schmid et al. 2001). This excitatory action of 
amylin in the AP appears to be mediated by the excitatory second messenger cGMP 
(Riediger, Schmid et al. 2001).
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1.3.2 Neuronal connections of the AP
The projections of the AP are predominantly efferent comprising 3 different functional 
groups. A first group of AP projections which are most relevant in the context of the present 
study have their termination field in the NTS and the parabrachial nucleus (PbN) as brain 
structures recognized to relay afferent visceral and gustatory information. Thus the AP is able 
to modulate enteroceptive signals of the periphery (van der Kooy and Koda 1983; Shapiro 
and Miselis 1985; Johnson and Gross 1993). These target structures are strongly 
interconnected with other nuclei located in more rostral brain areas including the CeA, BST 
and hypothalamic centers, amongst others the lateral hypothalamic area (LHA), formerly
recognized as “hunger center” (Ricardo and Koh 1978; van der Kooy, Koda et al. 1984).
The second group of efferent connections project to catecholaminergic cells of the 
dorsolateral tegmentum system. Both ascending and descending projections to cortical limbic 
and hypothalamic centers and intermediolateral sympathetic neurons of the spinal cord, 
respectively, are influenced by these projections. The last group of efferent projections 
connects the AP with the dorsal motor nucleus of the vagus (DMNV) and the nucleus 
ambiguous. These connections modulate the parasympathetic outflow of these nuclei to the 
viscera.
Apart from efferent connections to several brain structures like the NTS and the PbN,
the AP also receives neuronal afferents from these centers. Additionally the AP receives
projections from hypothalamic nuclei as the major central afferent input to the AP, e.g. from 
the paraventricular (PVH) and dorsomedial (DMH) hypothalamic nuclei, and the 
perifornicular region (Shapiro and Miselis 1985).
In summary the AP holds a unique position to receive and modulate ascending and 
descending information and to interconnect different signals from various structures of the 
brain and the periphery.
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1.4 Neurotrophic effects
The development of the rodent brain is not completed at the time of birth and certain 
circulating hormones, e.g. sex hormones, influence brain development and the formation of 
different central pathways (Rhees, Shryne et al. 1990; Ibanez, Gu et al. 2001). Various studies 
implied that hormones involved in the control of food intake and energy homeostasis may 
also exert neurotrophic effects in the developing brain.
Ghrelin, a 28 amino acid gastric peptide hormone, regulates the secretion of growth 
hormone and plays a role as an orexigenic signal in controlling feeding behaviour and energy 
homeostasis. In rats ghrelin stimulates food intake, induces adiposity, and increases body 
weight (Tschop, Smiley et al. 2000; Wren, Small et al. 2000). Ghrelin acts directly on 
neurones of the DMNV (Zhang, Lin et al. 2004) and neurones of the NTS (Zhang, Hu et al. 
2005) to stimulate neurogenesis both in vivo and in vitro.
Leptin has been supposed to have important trophic actions on neurons in the CNS. As 
mentioned above, the ARH is a major site of leptin’s actions on feeding and energy balance. 
Leptin has direct access to the hypothalamic neurons via the ARH (Sawchenko 1998; 
Elmquist, Elias et al. 1999) and cells of the ARH express leptin receptors (Fei, Okano et al. 
1997; Elmquist, Bjorbaek et al. 1998). Projections to other hypothalamic nuclei such as the 
PVH and DMH, as well as the LHA belong to the hypothalamic neurocircuitry involved in 
leptin signalling.
Although it has been shown that leptin receptors are also expressed in the brain of 
foetal and neonatal rats and mice (Matsuda, Yokota et al. 1999; Udagawa, Hatta et al. 2000),
the neonatal brain is only marginally susceptive to leptin’s action (Mistry, Swick et al. 1999).
In contrast to leptin’s effects in adults, leptin is unable to inhibit growth, food intake, or 
energy expenditure during the postnatal period (Mistry, Swick et al. 1999; Ahima and 
Hileman 2000; Proulx, Richard et al. 2002). Interestingly, postnatal plasma leptin levels are 
markedly elevated in the second week of life and decline to adult values around weaning
(Devaskar, Ollesch et al. 1997; Ahima, Prabakaran et al. 1998). A possible role for the 
occurrence of this neonatal leptin surge has been supposed to be that of an important 
developmental neurotrophic signal. Steppan et al. (1999) demonstrated that brains of ob/ob
mice, i.e. mice which lack leptin production, are smaller in weight and cortical volume
(Steppan and Swick 1999). Furthermore a daily IP injection of leptin for 2 weeks to 4-week-
old ob/ob mice caused an increased brain weight and appeared to be partially a result of 
increased cell number. Besides the decreased brain weight in leptin deficient mice, an 
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immature expression pattern of synaptic and glial proteins as neuronal and glial markers was 
observed. After six weeks of leptin treatment, both brain weight and protein content were 
increased (Ahima, Bjorbaek et al. 1999).
Important evidence for leptin’s role in brain development was provided by studies 
using DiI axonal labelling. Bouret et al. (2004a) demonstrated that ARH projections to the 
hypothalamic paraventricular nucleus are immature at birth and develop mainly during the 
second week of life (Bouret, Draper et al. 2004a). The development of these ARH projections 
after birth coincides with the naturally occurring surge of leptin during this time period.
Interestingly, the neuronal projection pathways from the ARH to the PVH are severely 
underdeveloped in leptin-deficient ob/ob mice. Treatment of adult mice with leptin does not 
recover these neuroanatomical defects (Bouret, Draper et al. 2004b) but daily treatment of 
ob/ob neonates with leptin from P4 to P12 rescues the development of these ARH projections. 
In line with this finding, leptin promotes neurite outgrowth from ARH neurons in vitro
(Bouret, Draper et al. 2004b). Hence, leptin plays an important role as neurotrophic factor
during the development of the rodent hypothalamus and this activity is confined to a critical 
period after birth (Bouret and Simerly 2004c; Bouret and Simerly 2006; Bouret and Simerly 
2007).
1.5 Amylin knockout mice
Amylin-deficient mice used in this study have been created to investigate the 
physiological role of amylin and the consequences of a lack of endogenous amylin. 
Generation of amylin-deficienct mice has been described previously by Gebre-Medhin et al., 
(1998a) (see chapter 2.1.1.1).
The mouse amylin gene is located on chromosome 6 and consists of three exons 
encoding preproamylin (Ekawa, Nishi et al. 1997). Exon 3 was targeted to generate amylin
knockout mice (Gebre-Medhin, Mulder et al. 1998a; Gebre-Medhin, Mulder et al. 1998b; 
Mulder, Gebre-Medhin et al. 2000; Carlsson, Karlsson et al. 2002). Amylin deficient mice 
(IAPP
-/-
) are phenotypically healthy and are born according to Mendelian frequencies when 
bred in transgenic colinies (Gebre-Medhin, Mulder et al. 1998b; Muff, Born et al. 2004).
They have normal basal plasma insulin and glucose levels, gonadal fat pad weight, islet 
weight, blood pressure, and blood perfusion of islets (Gebre-Medhin, Mulder et al. 1998b; 
Carlsson, Karlsson et al. 2002). Concerning the bone metabolism, IAPP
-/-
mice have low bone 
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mass with decreased cortical and trabecular thickness and connectivity (Dacquin, Davey et al. 
2004).
Amylin knockout mice have also been used to study the physiological role of amylin 
in the control of food intake and body weight (Lutz 2006). A comparison of body weight of 5 
months old mice demonstrated no difference between knockout and wildtype animals but 
IAPP
-/-
 mice showed a higher rate of body weight gain compared with corresponding wildtype 
controls. Food intake was slightly but non-significantly higher in amylin IAPP
-/-
 mice than in 
control animals (Mollet, Meier et al. 2003; Lutz 2005).
1.6 Aim of the study
Apart from various effects on food intake and energy homeostasis (see chapter 1.2.2),
amylin has been shown to play a role in developmental processes in the immature rodent 
organism. Amylin is already expressed in the foetal period suggesting an effect as growth 
factor at this developmental stage (Rindi, Terenghi et al. 1991; Mulder, Ekelund et al. 1997).
Trophic effects of amylin have been described in different tissues. Amylin stimulates 
osteoblast proliferation (Cornish, Callon et al. 1995) and osteoclast differentation (Cornish, 
Callon et al. 2001), and it plays an important role as a growth factor in kidney development 
(Harris, Cooper et al. 1997; Wookey, Tikellis et al. 1998). Furthermore amylin’s trophic 
effect has also been demonstrated in isolated foetal pancreatic cells suggesting a potential role 
as regulator of proliferation in neonatal pancreatic islet (Karlsson and Sandler 2001). Up to
now, there are no studies investigating trophic effects of amylin in the CNS.
Based on a similar approach replicating the experiments on leptin’s role in the 
development of the hypothalamic neuro-circuits involved in the control of eating, we used DiI 
axonal labelling in amylin deficient mice to investigate whether amylin may also function as a 
neurotrophic factor in the hindbrain. We established a neuronal tracing technique to analyse
the development of projections connecting the AP to the NTS.
We expected that amylin may participate in the development of efferent neuronal 
projections originating from the AP and projecting to the NTS, hence in principle similar to 
what has been shown for leptin’s neurotrophic effect in the hypothalamus. Thus, we 
hypothesised that IAPP
-/-
 mice have a reduced fiber density in the NTS compared to wildtype 
littermate animals.
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We wanted to answer the following questions:
• Does amylin contribute to the development of neuronal projections originating in the 
AP by exerting a neurotrophic effect? Is amylin deficiency associated with a reduced 
density of neuronal fibers in the AP/NTS region?
• Does the neurotrophic effect of amylin on the development of neuronal projections 
differ at various timepoints in the postnatal period?
• Does the neurotrophic effect of amylin on development of neuronal projections differ 
between male and female animals?
• Are postnatal plasma amylin levels in wildtype mice similar to or even higher than 
amylin concentrations in adult animals? The latter could be indicative of amylin being
a neurotrophic signal during the early developmental stage.
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2 Animals, materials, methods
2.1 Animals and housing
2.1.1 Animals
2.1.1.1 Generation of amylin knockout mice
Generation of amylin-deficient mice has been described previously by Gebre-Medhin 
et al., (1998b). Briefly, IAPP
-/-
 mice were created by cloning a 10.5-kbp fragment containing 
the murine IAPP gene from a genomic mouse Balb/c library (Stratagene) by plaque 
hybridization to the human amylin cDNA. An 890bp SphI/BamHI fragment containing part of 
exon 3, and internal to a 3.46kbp HindIII/XbaI fragment, was replaced by a phosphoglycerate 
kinase (PGK) promoter-driven neomycin resistance gene (neo)-selection cassette (Fig. 2.).
This resulted in the deletion of all sequence encoding the 37-amino-acid IAPP peptide. The 
resulting DNA construct was fused with a 5.1kbp XbaI/SalI fragment. Mouse 129Ola/sv 
embryonic stem cells were cultured and transfected, screened for recombinant ES cell clones, 
and therefore chimeric mice were generated.
The screening probe was a 1.5kbp EcoRI-HindIII genomic DNA fragment which 
contained the second exon of the IAPP gene. The deletion of the IAPP coding sequence in the
targeted IAPP allele was confirmed using exon 3-specific oligonucleotide probes bp 89-179 
and bp 170-253 of the mouse IAPP sequence. These probes were radio labelled using 5’ 
GTTGCTGGAA3’ and 5’CCTAGGGGAC3’, respectively, as primers in the presence of 
dCTP, unlabelled dATP, dTTP, and dGTP and the Klenow fragment of DNA polymerase I. 
Hybridizations were carried out at high stringency.
For our studies, we did not generate the knockout mice ourselves, but our breeders 
were supplied by Amylin Pharmaceuticals, Inc., USA (see 2.1.1.2).
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Fig. 2. IAPP gene-targeting strategy (adapted from Gebre-Medhin et al., 1998b)
a) Schematic map of the murine IAPP locus with the sequence coding for mature IAPP 
boxed in the third exon, and the screening probe containing exon 2. b) The targeting 
construct designed to replace the IAPP coding sequence present in exon 3 with a 
neomycin-resistance gene (neo)-selection marker. c) The IAPP locus following 
homologous recombination. The screening probe detects the wildtype IAPP locus as a 
12kbp EcoRI DNA restriction fragment, while the recombinant IAPP locus is detected as 
a 3.5kbp EcoRI fragment. R, EcoRI; B, BamHI; H, HindIII; S, SalI; Sp, SphI; X, XbaI.
2.1.1.2 Animal breeding
For the present studies it was important to use IAPP
-/-
and IAPP
+/+
littermates in order 
to minimize all prenatal developmental influences unrelated to amylin deficiency. Therefore 
heterozygous breeding pairs (IAPP
+/-
) were generated. Homozygous amylin knockout mice 
were obtained from Amylin Pharmaceuticals, Inc., USA. As shown in Figure 3 the transgenic 
mice were crossbred with C57BL/6 wildtype mice (Jackson Laboratories, USA) to generate 
heterozygous animals (F1). Breeding pairs from the heterozygous F1 generation were used to 
generate F2 animals. According to the Mendelian inheritance, F2 animals were expected to 
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comprise 25% BL/6 homozygous IAPP
+/+
wildtype (wt), 50% heterozygous (het) IAPP
+/-
and 
25% IAPP
-/-
knockout (ko) mice (ratio of 1:2:1).
C57BL/6 wt X IAPP
-/-
ko P
IAPP
+/-
 het F1
IAPP
+/-
 het X IAPP
+/-
 het F1
25% IAPP
+/+
 wt 50% IAPP
+/-
 het 25% IAPP
-/-
 ko
F2
Fig. 3. Breeding of the transgenic mice. Expected distribution of genotypes in the 
F2 generation. IAPP
-/-
 breeders were obtained from Amylin Pharmaceuticals, Inc., USA,
C57/BL6 breeders were obtained from Jackson Laboratories, USA.
For DiI-labelling experiments, male and female IAPP
-/-
 mice and their IAPP
+/+
littermates were used on day 10 and 14 after birth (P10, P14), respectively, to compare the
density of the projection neurons from the AP to the NTS. Wildtype BL/6 mice (P6 to P9) 
were used to measure the postnatal plasma amylin levels. Experiments were in accordance 
with the guidelines of the Veterinary Office of the Canton Zurich, Switzerland.
All animals were kept in standard macrolon cages until they were used for the 
experiments. The breeding pairs had ad libitum access to food (standard pellet chow, #3430, 
Kliba Nafag AG, Gossau, Switzerland) and water. The litters were housed in the same cages 
as their parents. Animals were kept under an artificial 12:12h light/dark cycle (lights off 
18.00h).
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2.2 DiI fiber labelling
2.2.1 Tissue fixation, perfusion
2.2.1.1 Material
1. Micro eye scissor (85mm, 3 3/8", B. Braun Medical AG, Tuttlingen, Germany)
2. Micro forceps (Jeweler Type, 0,3mm, angled, 110mm, 4 3/8", B. Braun Medical AG)
3. Canulae to fix extremity (Terumo, 26G x  “, Leuven, Belgium)
4. Three-way stopcock (B. Braun Medical AG) with flexible tubes
5. Clamp to fix perfusion canula in the left ventricle
6. 1ml syringes (Omnifix 1ml, Braun Melsungen AG, Melsungen, Germany)
7. Canulae (Terumo, 26G x  “, Leuven, Belgium)
8. 4% paraformaldehyde in sodium phosphat buffer (pH = 7.4)
a. Paraformaldehyde purum, 95.0% (Sigma-Aldrich, Saint Louis MO, USA)
b. Stock solution I (Tab. 1.)
c. Stock solution II (Tab. 1.)
9. 0.9% NaCl
10. Tribromoethanol (0.15 - 0.2ml for P7 - P14 pups) (Tab. 2.)
a. Stock solution:
• 2,2,2-Tribromoethanol (Aldrich Chemical, St. Louis, MO. USA)
• Ter-amyl alcohol-gold label reagent (Aldrich Chemical)
b. Working solution:
• TB EtOH
• 100% EtOH
• 0.7% saline
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Table 1. Reagents for perfusion
Stock solution Substance Concentration [g/l] End concentration in PB [M]
I NaH2PO4 · H2O 27.6 0.2
II Na2HPO4 · 2H2O 35.85 0.2
0.9% NaCl NaCl 9 0.15
Preparation of working solution: 500ml ddH2O + 40g paraformaldehyde + 2 pellets of NaOH 
(approx. 370mg) were stired and heated. Solution was filtered into 115ml of Stock solution I + 
385ml of Stock solution II. Finally the pH value was adjusted to 7.4 using HCl.
Table 2. Tribromoethanol
Solution Preparation
Stock solution
100g 2,2,2-Tribromoethanol dissolved in 62.5ml of Ter-amyl alcohol-
gold label reagent (Kantonsapotheke Zürich KAZ)
Working solution 2ml TB EtOH + 8ml 100% EtOH + 90ml 0.7% saline
2.2.1.2 Method
Anaesthesia
Animals were deeply anesthetised with intraperitoneally injected tribromoethanol 
(dose = 0.15 - 0.2ml for P7 - P14 pups). The injection site was slightly paramedian between 
teats and knee flexure and the needle penetrated at an angle in direction to craniomedial.
Tribromoethanol was used instead of pentobarbituric acid because it induces anesthesia 
rapidly and provides good surgical analgesia for approximately one hour. It produces a high 
degree of surgical tolerance and a strong anaesthetic depth. Moreover its analgetic properties 
are stronger compared to pentobarbituric acid whereas its depressive effect of the respiratory 
system is lower. All these factors are critical for anaesthesia of neonatal mouse pups. 
Anaesthetic depth was confirmed by testing the loss of the flexor reflex of the hind leg with a 
forceps.
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Transcardial perfusion
As soon as the anaesthesia was deep enough, the four legs were fixed with canulae to 
keep the animal in supine position. After dissecting the skin, the abdomen was opened at the 
level of the xiphoid process avoiding cutting the liver. The diaphragm was cut through and 
the thoracic cavity was opened by transecting the costal arches. The heart was carefully 
exposed and the pericardium was removed. After cutting the ventral part of the left ventricle, 
a blunt canula-needle was inserted into the incision without reaching the aorta. The needle 
was fixed with a mini-clamp. The right atrium was then cut with a micro eye scissor before 
the infusion of a 0.9% NaCl solution into the left ventricle with a hydrostatic pressure of 
about 150cm for approximately 2 minutes. After exsanguination the three-way stopcock was 
turned to infuse the ice-cold paraformaldehyde solution for approximately 6-7 minutes.
After perfusion animals were decapitated and the skullcap was carefully exposed. The 
brains were quickly removed and post fixed in the same 4% paraformaldehyde solution at 4°C
for about 10 days until further processing.
2.2.2 DiI implantation
2.2.2.1 Material
1. DiI C18 (1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine perchlorate, 
Molecular Probes, Eugene, OR), carbocyanine dye used for tracing
2. Micrometer benchmark (100 x 0.01mm, Pyser-SGI Limited, Kent, UK)
3. Insect pin (Minutien, 0.1mm, Bauer Handels GmbH, Adetswil, Switzerland)
4. Zoom stereomicroscope (Wild M8, Leica Microsystems, Nussloch, Germany)
5. Methylene blue for visualization of morphological features of brains during DiI 
implantation
6. 3 way micromanipulator (SD Instruments, Grants Pass, OR, USA)
7. Dual arm fiber optic illuminator (Intralux
®
 4000, Volpi AG, Schlieren, Switzerland)
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2.2.2.2 Method of implantation
The cerebellum was carefully removed under a stereomicroscope (see Fig. 4.A) to 
expose the area postrema (AP). To visualize morphological features of the exposed surface,
methylene blue was used to identify structures of the medulla oblongata. An insect pin was 
used to implant a small crystal (~10µm diameter) of the lipophilic tracer DiI into the AP.
Before implantation, each DiI-crystal was first checked for uniform size and shape using a
micrometer benchmark under the zoom stereomicroscope. The crystals used for implantation 
had a round shape and a diameter of approximately 10µm.
Under visual guidance and using a micromanipulator, the DiI crystal was first placed 
on the surface of the AP at the desired implantation site without penetrating the tissue. 
Afterwards it was pushed into the tissue slightly under the surface with the insect pin. The 
implantation site was in the center of the horizontal AP surface area (see Fig. 4. + 5.). After 
implantation, brains were stored in glass vials in a 4% paraformaldehyde solution. The DiI 
tracer was allowed to migrate for 10 days in the dark at 37°C.
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Fig. 4. Surface-area of the AP and implantation site of the DiI crystal
A. Borderline of the AP showed as dotted line
B. Detail enlargement of A (white box); the black dot indicates the implantation site
AP = area postrema, Cu = cuneate nucleus, Gr = gracile nucleus, Ve = vestibular 
nucleus
A
B
AP
Gr
Gr
Ve
Ve
Cu
Cu
3mm
1mm
ANIMALS, MATERIALS, METHODS
22
2.2.3 Brain slicing
2.2.3.1 Material
1. Vibratome (Leica VT 1000s, Leica Microsystems)
2. Agarose (agarose electrophoresis grade, #820723, MP Biomedicals, Inc., Solon, Ohio,
USA)
3. KPBS buffer (0.02M) (Tab. 3.)
4. Multi-well plate (24 Well)
5. Paint brush
6. Poly-L-lysine-coated (Sigma-Aldrich, Inc.) glass slides (Thermo Scienctific, 
microscope slides 76 x 26mm, Menzel GmbH & Co. KG, Braunschweig, Germany)
7. 65% KPBS buffered glycerol
8. Microscopic cover slips (24 x 50mm, Menzel GmbH & Co. KG)
9. Rapid mounting medium (Entellan
®
, Merck, Darmstadt, Germany)
Table 3. Composition of KPBS buffer (0.02M)
Substance Weight [g]
KH2PO4 9.7
K2HPO4 56.6
NaCl 178.2
Dissolved in 20.58l H2O to 
final concentration of 0.02M
2.2.3.2 Preparation of brain slices
After the 10 day incubation period, brains were embedded in 3% agarose. The brains 
were transected at the mid rostrocaudal level to facilitate embedding in an upright position 
along the longitudinal axis. The agarose blocks were trimmed and fixed with super glue. 
80µm thick coronal sections were cut through the brainstem using a vibratome. The brains 
were cut approximately between bregma -7.08mm to -8.24mm (see Fig. 5., bregma levels 
corresponding to adult mice). The slices were collected with a soft paint brush and kept in 
KPBS before mounting onto poly-L-lysine-coated glass slides and coverslipped with 65%
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KPBS buffered glycerol. Coverslips were finally sealed with rapid mounting medium and the 
slices were stored at 4°C in the dark.
Fig. 5. Coronal diagramm of the brainstem illustrating DiI implantation site 
in the AP (adapted from Paxinos and Franklin, 2004; image and specifications 
corresponding to adult mice)
The DiI crystal was implanted slightly under the surface in the center of the horizontal
surface area of the AP (tip of the triangle).
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2.2.4 Microscopy
2.2.4.1 Fluorescence microscopy
Material
1. Fluorescence microscope (Zeiss Axioskop 2, upright epifluorescence microscope,
Zeiss Co., Oberkochen, Germany)
2. Fluorescence filter set 43 (Zeiss Co.; excitation BP 545/25nm, emission BP 
605/70nm, Fig. 7.), optimized for DiI dye (excitation/emission, 551/565nm, Fig. 6.)
3. Microscopy digital camera (AxioCam HS, Zeiss Co.)
Method
Sections were evaluated with both conventional fluorescence and confocal microscopy
(see 2.2.4.2). The accuracy of the crystal implantation was a precondition for a correct 
evaluation of all following analyses. Therefore, the success of the crystal implantation was 
confirmed with the fluorescence microscope equipped with optics for visualization of DiI 
fluorescence (Fluorescence Filter set 43, Zeiss Co.). Figures 6 + 7 show the spectral range of 
excitation and emission spectra of DiI dye and the Filterset 43. A crystal implantation was 
considered successful when the following criteria were met:
• Implantation of crystal
It was first checked, if the crystal was really implanted into the AP because it could 
have been implanted too superficially and get lost during processing.
• Symmetry of implantation
The crystal had to be implanted exactly in the middle of the AP to achieve a
symmetric diffusion area. As a consequence, the tracer is able to migrate and 
distribute uniformly. This was a precondition for a comparable specific labelling.
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• Restricted tracer diffusion area
The unspecific tracer signal caused by diffusion of the tracer around the implantation 
site had to be restricted to the AP.
• Distribution and extent of fibers (AP, NTS)
The distribution and extent of fibers in the AP and through the NTS were roughly 
evaluated in the fluorescence microscope. In case of an unusual distribution (e.g. 
asymmetric distribution pattern) or if the tissue was damaged, the animals were not 
included in further evaluation.
For the documentation of the implantation site pictures were taken with a digital camera in 
different magnifications and section planes.
excitation (551nm) emission (565nm)
Fig. 6. Spectral range of dye DiI (adapted from Zeiss Co., Germany)
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Fig. 7. Spectral range of filterset 43 (adapted from Zeiss Co.,
Germany)
2.2.4.2 Confocal laser microscopy
Equipment and material
1. Confocal laser-scanning microscope (Leica SP2 AOBS, Leica Microsystems, Wetzlar,
Germany)
2. 63x glycerol objective (Leica, HCX PL APO lbd. BL 63x 1.4 CORR)
3. 20x multi objective (Leica, HC PL APO lbd. BL 20x 0.7 IMM / CORR)
Images of DiI-labeled fibers were collected through the NTS region (Fig. 8., white 
rectangle) by using a confocal laser-scanning microscope. Within each tissue section the NTS 
region was analysed with a 63x glycerol objective to detect projections from the AP to the 
NTS. Furthermore a 20x multi objective was used to acquire overview images. The image 
stacks were collected with a pinhole setting of Airy 1 (232.43m) and a step length of 0.8m.
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The following settings of the confocal laser-scanning microscope were used to analyse 
representative sections:
• Laser: 543nm excitation
• Airy 1 pinhole: 232.43m
• Scan Averaging 6
• Series: The z-Axis interval was adjusted by scanning a 60m thick 
bloc with a 0.8m step length
• Gain, Offset manually adjusted
Confocal microscope settings were adjusted to optimize the signal : noise ratio. A single 
image stack comprised 75 images with a thickness of 0.8m each, i.e. a total of 60m.
Fig. 8. Fluorescence microscopic image illustrating confocal 
scanning area in the NTS (white rectangle); NTS = nucleus of the 
solitary tract
NTS
10x 200µm
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2.2.5 Quantitative analysis
Image analysis (three-dimensional reconstruction, volume and surface rendering) was 
performed using image analysis software (Imaris Vers 6.0.1, Bitplane, Zurich, Switzerland). 
After importing the image stacks of optical sections into the analysis application, a filament 
tracer software module with an autopath algorithm was used to calculate the total fiber length 
contained in the entire volume of the image stack (3.4 x 10
-3
mm
3
). This algorithm generates a 
filament by connecting start- and endpoints based on local intensity contrast. The signal range 
of the start- and endpoints was manually set by a thresholding procedure. Afterwards, fibers 
were skeletonized to a diameter of 1 pixel. The software calculated different parameters of the 
digitalized fiber skeleton from which the total fiber length in the entire image stack was used 
for the evaluation.
2.3 Postnatal plasma amylin levels
2.3.1 Blood samples
Material
1. EDTA tripotassium salt blood collection tube (Microvette 200 K3E, Sarstedt AG, 
Sevelen, Switzerland)
2. Aprotinin (Protease inhibitor, Labodia SA, Yens, Switzerland)
3. Canulae (Terumo, 26G x  “)
Method
To measure the postnatal plasma amylin levels, blood samples from BL/6 wildtype 
mice were taken at different time points (P6 - P9) after birth. Mouse pups were anesthetised 
with an IP Injection of Tribromoethanol (0.15 - 0.2ml for P6-P9 pups). After checking the 
loss of flexor reflexes, the abdomen and the thorax were opened and the heart was carefully 
exposed. The pericardium was removed before the right ventricle was penetrated with a 
canula that was attached to a pipette tip. This method had several advantages such as holding 
ANIMALS, MATERIALS, METHODS
29
the needle in proper position. Furthermore the blood could be taken easily with one hand and 
easier than with a normal syringe. The experiment was terminal for the animals.
Blood was immediately transferred into EDTA tubes. The protease inhibitor aprotinin 
was added instantly. Blood was cooled on ice until centrifugation. An approximate amount of 
100l (P6) - 200l (P9) of blood per animal was obtained. Samples were centrifuged
immediately for 10min at 2800rpm to separate blood plasma. Plasma was subsequently 
transferred into Eppendorf tubes and stored at -20°C until further processing.
2.3.2 Immunoassay for plasma amylin levels
Material
1. Mouse Endocrine LINCOplex
™
 KIT - 96 well plate assay (Linco Research, Inc. St 
Charles Missouri, USA)
2. Luminex Sheath Fluid
3. Sonicator
4. Titer plate shaker
5. Vacuum pump for vacuum filtration
6. Luminex 100 analyzer (Luminex Corp., Austin, TX, USA)
Method
For the analysis of plasma samples, the Mouse Endocrine LINCOplex
™
 assay, a 
multianalyte detection system, was conducted according to the manufacturer’s instructions 
(Linco Research, Inc.). Briefly, the assay is based on conventional sandwich assay technology 
and permits simultaneous detection of multiple hormones from a single sample. The antibody 
specific for the hormone of interest is covalently coupled to Luminex microspheres uniquely 
labelled with a fluorescent dye.
The microspheres were incubated with standards, controls, and the plasma samples 
(10l) in a 96-well microtiter filter plate with agitation on a plate shaker overnight (17 hours) 
at 2-8°C. After incubation, the plate was washed 3 times with an assay wash buffer 
(200µl/well) to remove excess reagents (by vacuum between each washing step) prior to the 
addition of the detection antibody (50µl/well). After 60min incubation on a plate shaker at
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room temperature, 50µl streptavidin-phycoerythrin was added to each well containing 50µl of 
detection antibody cocktail, and incubated for an additional 30min.
After a final washing step (3 times washing and removing fluids by vacuum filtration), 
the beads were resuspended in buffer (100µl of Sheath Fluid) and the plate was analyzed 
using the Luminex 100 analyzer to determine the concentration of the hormones of interest 
(Precision for amylin: Intra-assay 3.8 – 10.6%, Inter-assay 4.8 – 20.7%, Accuracy: 80.2%).
2.4 Genotyping of IAPP- ko and wildtype mice with PCR
In the present study IAPP
-/-
 mice and their wildtype littermates were used. All animals 
were generated from heterozygous breeding pairs. Since the genotype of the newborn mouse 
pups was not known at the time of DiI implantation, all animals had to be genotyped in 
retrospect. The genotyping was partly conducted externally via a molecular diagnostics 
company (Transnetyx, Memphis, TN, USA). The genotyping procedure conducted externally 
involved a fully automated real time PCR and yields an accuracy of 99.973%. Each sample 
was tested twice and validated against a housekeeping gene. In addition a new PCR was 
established in collaboration with Michael Koss (Institute of Animal Sciences, ETH Zurich)
(see 2.4.2).
2.4.1 Tail samples, mouse tail tip amputation
Biopsies from mouse pups were taken during the perfusion. About 0.5 - 1.0cm of the 
tail tip was cut with a sharp scissor and the tissue was collected in labelled 1.5ml Eppendorf 
tubes. The collected specimens were stored at -20°C until analysed.
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2.4.2 Establishment of multiplex PCR
2.4.2.1 DNA preparation from tissue (mouse tail tip) with isopropanol-precipitation
Material
1. Thermal shaker
2. Solubilization buffer (500l, Tab. 4.)
3. Proteinase K (50l) (Promega Co, Madison, USA)
4. Tail salt solution (200l per tail tip, Tab. 5.)
5. Isopropanol
6. 70% ethanol (ice cold, stored in -20°C)
7. TE (Tris-EDTA buffer) (Tab. 6.)
Method
The mouse tail tips were transferred into labelled Eppendorf tubes containing 
solubilization buffer plus proteinase K. The tubes were incubated at 55°C on a thermal-shaker 
with 950rpm followed by addition of tail salt solution for a further incubation of 30min before 
samples were centrifuged for 10min at 4°C (13000rpm). The supernatant was transferred into 
new tubes and isopropanol was added. The samples were centrifuged for another 30min at 
4°C (15000rpm). The supernatant was carefully decanted and the pellet was washed by 
adding ice cold 70% ethanol followed by a last centrifugation step for 15min at 4°C. Finally, 
the supernatant was completely removed with a pipette and the pellet was air dried for about 
20min before the DNA pellet was re-dissolved with TE buffer (55°C, 150rpm, 1-2h or over 
night at room temperature).
Addition of 550l per tail tip
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Table 4. Mouse tail solubilization buffer (50ml buffer)
Substance Stock concentration Volume [ml] End concentration
SDS 10% 5 1%
Sodium acetate 3M 5 0.3M
EDTA 50mM 1 1mM
Tris-HCl (pH 6.8) 1M 0.5 10mM
Filled up to 50ml with aqua dest.
Table 5. Tail salt solution (50ml solution)
Substance Concentration [g/50ml] End concentration [M]
NaCl 12.3 4.21
KCl 2.3 0.63
Filled up to 45ml with Tris-HCl (10mM), pH adjusted to 8.0 (HCl or NaOH), filled up to 50ml
Table 6. TE buffer
Substance Concentration
Tris-HCl pH 8.0 1mM
EDTA 0.1mM
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2.4.2.2 DNA amplification with PCR Thermocycler (multiplex protocol)
Material
1. H2O
2. Green PCR-Buffer (Promega Co, Madison, USA)
3. MgCl2 (Promega Co.)
4. dNTP’s (Promega Co.)
5. Primer Nr. 206 (10µM) ko
6. Primer Nr. 207 (10µM) ko
7. Primer Nr. 208 (10µM) wt 
8. Primer Nr. 209 (10µM) wt
9. Go-Taq
®
 Flexi DNA Polymerase (Promega Co.)
10. DNA-template
Method
Genotype-specific primers are listed in Table 7. All reagents of the mastermix (shown 
in Tab. 8.) were mixed and transferred to sterile 200µl tubes before 1µl DNA template was 
added into each tube to a total volume of 25µl. All tubes were then placed in a PCR 
thermocycler with the program conditions as follows (see also Tab. 9.): denaturation at 94°C 
for 1min followed by 40 cycles of 92°C melting for 30s, annealing at 62°C for 30s and
synthesis at 72°C for 30s, followed by a final incubation for extension at 72°C for 5min. The 
samples were then kept at 4°C.
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Table 7. Genotyping primers used
Primer Sequence (5' - 3')
Length 
[mer]
Tm [°C] Location
Product size
[bp]
Primer for IAPP ko Neo
206 cttgggtggagaggctattc 20 58.7°C/57.5
207 cacagctgcgcaaggaac 18 61.8°C/57.1
Chromosome 6 200
Primer for IAPP wt (replaced sequence in ko)
208 gtagcaaccctcagatggac 20 57.2°C/57.5
209 gaggactggaccaaggttgt 20 59.0°C/57.5
Chromosome 6 107
Table 8. PCR-Master-Mix (1x) + DNA template
Volume Substance Concentration
14.375µl H2O
5,0µl Green PCR-Buffer (5x)
2.0µl MgCl2 25mM
0,5µl dNTP’s 10mM each 0.1mM each dNTP
0,5µl Primer Nr. 206 ko 10µM
0,5µl Primer Nr. 207 ko 10µM
0,5µl Primer Nr. 208 wt 10µM
0,5µl Primer Nr. 209 wt 10µM
0,125µl Go-TaqPolymerase 5u/µl 0.625u
1µl DNA-template (or H2O control)
Total Volume of 25µl
Table 9. PCR conditions
Cycles Time Temperature Process step
1 1’ 94°C Start
30’’ 92°C Melting
30’’ 62°C Annealing40
30’’ 72°C Synthesis
1 5’ 72°C Synthesis
 4°C hold
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2.4.2.3 Separation of PCR products
Horizontal electrophoresis through a 2.0% agarose gel was used to separate PCR products.
Material
1. Agarose (Agarose electrophoresis grade, #820723, MP Biomedicals, Inc., Solon, 
Ohio, USA)
2. Ethidiumbromid 
3. DNA ladder: 100bp (Fermentas International Inc., Canada)
4. TBE buffer (buffer solution containing a mixture of Tris base, boric acid and EDTA)
Preparation of a 2.0% agarose gel
2.0g of agarose was dissolved in 100ml 1x TBE buffer (Tab. 10.) and heated in a
microwave until it was completely dissolved. The solution was cooled for a few minutes and 
afterwards, 2µl of ethidium bromide (staining for visualization PCR products) were added and 
mixed without creating bubbles.
The gel was poured in an electrophoresis chamber and the chamber comb was inserted 
before the gel cooled completely and solidified. Bubbles were removed using a pipette tip. 
The chamber was filled with 1x TBE buffer to cover the gel with a layer of about 3 - 5mm. 
Afterwards the comb was removed.
Table 10. 1x TBE buffer
Substance Concentration [g/10l] End concentration [mM]
Tris-HCl pH 8.0 108 89
Boric acid 55 89
EDTA 74.4 20
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Sample preparation
Because the PCR was done with Go-Taq-polymerase and Green PCR-Buffer the PCR 
products could directly be loaded into the gel slots, in parallel with a DNA molecular weight
marker (100bp DNA Ladder) for size estimation. 12µl of each sample and the DNA marker 
were carefully filled in with a pipette and the electrophoresis was run at 140V for 40min until 
the yellow dye of the Green PCR Buffer reached the end of the gel. Representative samples 
were used as positive control and distilled water as negative control (ntc).
After the electrophoresis the gel was exposed to UV-light for visualization and 
documentation of the amplicons. The amplicons had the following expected sizes in the 
different genotypes:
Table 11. Expected bands
Genotype Primers Ampificat size
206/207 200bp (neo insert)
-/- knockout
208/209 no product
206/207 200bp
+/- heterozygous
208/209 107bp
206/207 no product
+/+ wildtype
208/209 107bp (IAPP)
2.5 Statistical analysis
All data were presented as means ± SEM. Statistical significance was determined by 
parametric t-test of data with normal distribution (Kolmogorov-Smirnov normality test) or
non-parametric Mann Whitney test using Prism Version 5.0a for Mac OS X (GraphPad 
Software Inc., San Diego, CA, USA). A p-value < 0.05 was considered to be statistically 
significant.
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3 Results
3.1 Genotyping
All animals used in this study were generated from heterozygous breeding pairs. 
Thereby the genotype of the offspring was not known at the time of DiI implantation. We 
designed a multiplex PCR protocol with four primers. Figure 9. shows a representative 
electrophoresis agarose gel demonstrating the estimated bands. The genotypes were identical 
to the results obtained by the external genotyping (Transnetyx).
Fig. 9. Electrophoresis agarose gel showing the amplicons of the 
multiplex PCR. The expected bands were 107bp (IAPP+/+), 200bp (IAPP-/-), 
and 200bp/107bp (IAPP
+/-
).
M = marker (100bp, 200bp), ntc = no template (neg.) control, -/- = ko IAPP
-/-
, +/+ = wt IAPP
+/+
, +/- = het IAPP
+/-
200bp
100bp
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3.2 Neurotrophic effect of amylin
3.2.1 Fiber density in the NTS on P10 and P14
The DiI tracing experiments were conducted with amylin knockout (IAPP
-/-
) mice 
(n=15) and their wildtype littermates (IAPP
+/+
) (n=17) on day 10 or 14 after birth,
respectibely. Representative implantation sites are shown in Figure 10. The diffusion fields of 
the tracer at the implantation sites were largely restricted to the AP.
Fig. 10. Implantation site of amylin knockout and wildtype mice
A IAPP
+/+
 mice, B IAPP
-/-
 mice
AP = area postrema, NTS = nucleus of the solitary tract, dashed line = 
borderline of the AP
A
AP
NTS NTS
200µm
B
AP
NTS NTS
200µm
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In 10 day old pups the fiber density (expressed as total fiber length in a volume of 3.4 x 
10
-3
mm
3
) in the NTS was significantly reduced in IAPP
-/-
 mice compared to their wildtype
littermates (males and females combined; ko: 8859 ± 2843µm vs. wt: 19769 ± 2428µm, p < 
0.01) (Fig. 11.). P14 IAPP
-/-
 mice also had lower fiber density than IAPP
+/+
 littermates (male 
and female combined; ko: 7162 ± 3050µm vs. wt: 11470 ± 2850µm, p = 0.3). However this 
difference did not reach statistical significance (Fig. 11.). The difference in fiber density 
between IAPP
-/-
 and IAPP
+/+
mice was more pronounced in P10 than in P14 animals (55% vs. 
35%). Confocal images in Figure 12 and + 13 demonstrate the lower fiber density of P10 and 
P14 IAPP
-/-
 mice compared to IAPP
+/+
.
The fiber density of 14 day old IAPP
+/+
 mice was lower compared to 10 day old IAPP
+/+
animals (P14 wt: 11470 ± 2850µm vs. P10 wt: 19770 ± 2428µm) but the difference just failed 
to be significant (p = 0.051). The fiber density of 14 day old IAPP
-/-
 mice compared to 10 day
old IAPP
-/-
mice was similar (P14 ko: 7162 ± 3050µm vs. P10 ko: 8859 ± 2843µm).
Fig. 11. Total fiber length in the NTS of P10 and P14 amylin knockout mice 
compared to wildtype littermates (males and females combined). The total 
fiber length contained in the entire volume of the image stack (3.4 x 10
-3
mm
3
) on P10 and 
P14 was measured. IAPP
-/-
 mice showed a significantly lower total fiber length compared 
to IAPP
+/+
 littermates on P10. The tendency was similar on P14.
All data are expressed as mean ± SEM: **, p < 0.01; IAPP
-/-
 vs. IAPP
+/+
; ns. = not 
significant
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Fig. 12. Representative three-dimensional confocal image stacks and 
skeletonized fiber tracings (male P10 mouse).
A + B Confocal images illustrating the fiber density in the NTS of P10 IAPP
-/-
compared to IAPP
+/+
 mice
C + D Fiber skeleton corresponding to the neuronal projections in A + B
IAPP
-/-
A B
IAPP
+/+
C D
IAPP
+/+ IAPP
-/-
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Fig. 13. Representative three-dimensional confocal image stacks and 
skeletonized fiber tracings (male P14 mouse).
A + B Confocal images illustrating the fiber density in the NTS of P14 IAPP
-/-
compared to IAPP
+/+
 mice
C + D Fiber skeleton corresponding to the neuronal projections in A + B
A
DC
B
IAPP
+/+
IAPP
+/+
IAPP
-/-
IAPP
-/-
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3.2.2 Fiber density in the NTS of male compared to female mice on P10
To investigate, if there was a difference in AP-NTS projections between male and 
female animals, we conducted a gender-specific analysis. Similar to the combined data, P10 
male IAPP
-/-
 mice had a significantly lower fiber density than male IAPP
+/+
 mice (P10 male 
ko: 10457 ± 3341µm vs. P10 male wt: 23162 ± 3265µm, p < 0.05). Female IAPP
-/-
 mice also 
had a much lower fiber density than female IAPP
+/+
 mice. However, these data were not 
evaluated statistically because after exclusion of unsuccessful implantations and heterozygous 
genotypes, the group size of the female IAPP
-/-
 mice (n=2) was too small for statistical 
analysis.
There seemed to be a tendency of a lower fiber density in female IAPP
+/+
 vs. male 
IAPP
+/+
 mice, but this difference was statistically not significant (P10 female wt: 15698 ±
2974µm vs. P10 male wt: 23162 ± 3265µm, p = 0.33).
Fig. 14. Total fiber length in the NTS of male and female amylin knockout 
mice compared to wildtype littermates. The total fiber length contained in the 
entire volume of the image stack (3.4 x 10
-3
mm
3
) on P10 was measured. The fiber density 
in female (f) IAPP
+/+
 mice was lower compared to male (m) IAPP
+/+
 but the difference 
was not significant. Male IAPP
-/-
 mice had a significantly lower fiber density compared 
to male IAPP
+/+
 mice.
All data are expressed as mean ±SEM: *, p< 0.05; female IAPP
+/+
 vs. male IAPP
+/+
; male 
IAPP
-/-
 vs. male IAPP
+/+
; ns. = not significant
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3.2.3 Projections outside the NTS
We observed in several DiI labelled brain slices large bilateral projections outside the NTS. 
The DiI dye migrated laterally from the implantation site in the AP through the NTS to other 
brain areas. These projections most likely correspond to AP projections described in studies 
using anterograde and retrograde axonal tracing techniques (van der Kooy and Koda 1983; 
Shapiro and Miselis 1985). The reported fibers projected to the parabrachial nucleus and 
demonstrated a similar bilateral distribution and pattern as the AP/NTS projections observed 
in our DiI labelling experiments (see Fig. 15.). We did not quantify postnatal differences in 
these projections between genotypes.
Fig. 15. DiI labelled neuronal projections (male wildtype mouse).
20X; dashed line = borderline of the AP; projections outside the NTS (with 
arrow)
AP = area postrema; NTS = nucleus of the solitary tract
20x
AP
NTS
100µm
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3.3 Postnatal amylin level in BL/6 wildtype mice from P6 to 
P9
We took blood samples of BL/6 wildtype mice in the postnatal period (from P6 to P9) 
to measure the postnatal plasma amylin levels. Amylin concentrations appeared to be stable 
during this time period (Fig. 16.). Animals from P6 to P9 had similar plasma amylin levels 
compared to published values from adult mice. Of note, however, the literature data of plasma 
amylin levels vary depending on methodology and experimental conditions. To our 
knowledge the only published data in adult ad libitum fed mice came from Leckstrom et al.,
(1999). In these studies a plasma amylin level of 14 ± 4pmol/l was reported for adult mice, 
measured by radioimmunoassay (Leckstrom, Lundquist et al. 1999).
Fig. 16. Postnatal plasma amylin levels in BL/6 mice. Plasma amylin 
levels measured on different days after birth (from P6 to P9). Mean adult 
plasma amylin levels are shown as dashed line (SEM range indicated as grey 
area). Amylin levels from P6 to P9 were similar to those in adult animals. 
No change in amylin levels was observed during this time period. P6 - P9 = 
postnatal days 6 – 9
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4 Discussion
This is the first study investigating a possible neurotrophic effect of amylin on the 
development of neuronal projections in the brain. Recent studies demonstrated a trophic effect 
for the lipostatic and anorectic hormone leptin in particular for projections from the ARH to 
the PVH, DMH, and LHA (Bouret, Draper et al. 2004a; Bouret, Draper et al. 2004b). Our 
hypothesis that amylin may exert a similar trophic action in the hindbrain, i.e. amylin’s 
primary target area for its eating inhibiting effect, was put forward by studies demonstrating a 
trophic action of amylin in different peripheral tissues, including the kidney, the pancreas and 
bone tissue (Cornish, Callon et al. 1995; Harris, Cooper et al. 1997; Wookey, Tikellis et al. 
1998; Cornish, Callon et al. 2001; Karlsson and Sandler 2001). On the basis of these findings,
we postulated a neurotrophic effect of the anorectic hormone amylin on the development of 
neuronal projections from the AP to the NTS. These projections are assumed to mediate part 
of amylin’s central nervous effects. To investigate amylin’s effect on the development of 
these AP-NTS projections we adapted the DiI tracing approach conducted by Bouret et al.,
(2004). We implanted crystals of the lipophilic DiI dye into the AP of amylin deficient (IAPP
-
/-
) mice and their wildtype (wt) littermates IAPP
+/+
on P10 and P14.
Our data provide first evidence that amylin plays a critical role for the development of 
AP-NTS projections because the neuronal pathways from the AP to the NTS are 
underdeveloped in amylin-deficient (IAPP
-/-
) mice compared to their wildtype littermates. 
Specifically the average fiber density (expressed as total fiber length in a volume of 3.4 x 10
-
3
mm
3
) in the NTS was significantly lower (55%) in IAPP
-/-
mice compared to IAPP
+/+
littermates on postnatal day 10. Interestingly, P14 IAPP
+/+
animals displayed a lower NTS 
fiber density than IAPP
+/+
mice on P10 although this difference just failed to reach statistical 
significance. Although the fiber density of P10 and P14 IAPP
-/-
was similarly low, the 
difference between P14 IAPP
+/+
 mice and their amylin deficient littermates was smaller than 
the difference observed on P10. In general the development of AP-NTS projections appeared 
to be disrupted both in male and female mice, although a statistical evaluation could only be 
conducted in male mice due to the low number of available female IAPP
-/-
mice. However, 
P10 IAPP
+/+
male and female animals did not significantly differ in their NTS fiber densities, 
although female mice tended to have lower values.
The different average fiber density between the NTS of IAPP
-/-
and IAPP
+/+
mice 
provides convincing evidence that amylin functions as a developmental neurotrophic factor in 
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the brain similar to what has been described for leptin (Bouret, Draper et al. 2004a; Bouret, 
Draper et al. 2004b) and for sex hormones (Rhees, Shryne et al. 1990; Ibanez, Gu et al. 2001).
In comparison to the leptin-dependent development of ARH-PVH projections, there 
seem to be some striking differences in the neuronal processes involved in the maturation of
AP-NTS projections. One characteristic of the fiber formation from the AP appears to be 
existence of regressive events affecting fiber outgrowth, which is reflected by a time 
dependent reduction of fiber density in IAPP
+/+
 pups at least between P10 and P14. Hence the 
maturation of projections in this brainstem area may not only involve fiber growth but also a
remodelling of fibers leading to a refinement of neuronal connectivity. Such processes have 
also been described in other neural systems characterized in neonates using the same DiI 
approach. For example, fiber remodelling that is associated by reduction in fiber density has 
been observed in retinocollicular projections during the postnatal phase until P12 (Simon and 
O'Leary 1990; Simon and O'Leary 1992). It has been suggested that a refinement is achieved 
by removal of axons, axon segments, branches and arbors from topographically inappropriate 
positions. From a functional point of view an early postnatal remodelling of AP efferents 
appears plausible because these projections are thought to modulate or converge with 
enteroceptive pathways in the NTS. These pathways probably increase their stimulatory input 
and become operational at the onset of ingestive behaviour after birth. It is therefore tempting 
to speculate whether an increase in enteroceptive signalling is a necessary factor triggering 
the refinement of pre-developed AP-NTS projections.
In addition to the apparent remodelling processes, a further difference between the 
development of ARH-PVH and AP-NTS projections seems to be the onset of development 
itself. While the efferent ARH projections show a comparatively late postnatal development 
between P8 and P10, the development of AP efferents obviously takes place at an earlier 
postnatal or even foetal stage. In relation to what has been discussed above, the question 
arises whether the time range of fiber development may be associated with or influenced by 
the onset of ingestive behaviour. With respect to the control of food intake, newborn neonates 
are challenged with a sudden change of nutrient supply at birth. While prenatal nutrient 
supply of the foetus depends on placental transfer of maternal metabolites, the necessity to 
control nutrient intake emerges during postnatal development. An early development of AP-
TNS connections may be an important requirement as soon as the animal is capable to control 
food intake. The ARH is thought to be an important target for adiposity signals involved in 
the long-term control of bodyweight. Apparently, the maturity of ARH-PVH projections 
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seems to be a less important prerequisite for the control of energy homeostasis during the 
early postnatal phase, which is in line with the unresponsiveness of newborn mouse pups to 
the anorectic action of leptin (Mistry, Swick et al. 1999).
Behavioural or functional neurophysiological studies characterizing amylin sensitivity 
in IAPP
-/-
 mice are scarce. Thus, it remains to be determined whether the disrupted 
development of AP projections translates into an attenuated amylin responsiveness. There are 
indications that 12h food deprived amylin knockout mice show a slightly but not significantly 
higher food intake and an increased body weight gain than wildtype control animals (Mollet, 
Meier et al. 2003; Lutz 2005). On one hand these effects may be due to the lack of amylin and 
its anorectic action, on the other hand food intake and body weight gain may be altered as a 
consequence of the immature neuroanatomy of amylin deficient mice.
Future studies should characterize the time course of fiber development at earlier and
later timepoints compared to the present work. It is of high interest to shed more light on the 
critical time window of fiber development and maturation. Furthermore, the basic question 
should be addressed whether amylin deficiency has an impact on the ingestive behaviour and 
neurophysiology in the mature adult brain. Feeding studies and immunohistological c-Fos 
studies characterizing the amylin responsiveness in IAPP
-/-
and IAPP
+/+
could be conducted to 
explore these issues.
An experimental approach to further substantiate the critical role of amylin as a 
neurotrophic factor may be an early postnatal amylin replacement in amylin deficient 
neonates. Interestingly, repeated daily leptin injection effectively rescues the disruption of 
ARH-PVH projection in postnatal leptin deficient ob/ob mice (Bouret, Draper et al. 2004b).
Whether a similar amylin treatment would also reverse the attenuated fiber growth in IAPP
-/-
mice probably depends on the time range when the developing brain is sensitive to the 
neurotrophic action of endogenous amylin, which is still unknown. Even DiI studies 
characterizing NTS fiber densities in IAPP
-/-
 mice at earlier developmental stages are not 
appropriate to identify this critical time window because genetic amylin deficiency is not a 
time dependent factor.
Possible indications about the critical time of amylin’s neurotrophic action may be 
derived from alterations in circulating amylin plasma levels, which for technical reasons 
(limited volume of blood samples) can only be determined in mouse pups after a certain age. 
Unlike the postnatal profile of leptin blood values with a peak on P10 (Ahima, Prabakaran et 
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al. 1998), we did not detect an early postnatal amylin surge at least between P6 and P9. 
Amylin plasma values were relatively constant and were in the range of amylin levels 
measured in ad libitum fed adult mice (Leckstrom, Lundquist et al. 1999). Thus, it is 
conceivable that amylin might influence the brain development already before P6, but it may 
be experimentally difficult to assess this by earlier amylin measurements.
The present study does not rule out that amylin may act prenatally to bring about its 
neurotrophic effect. Our observations suggest ongoing maturation processes between P10 and 
P14 that may be important by amylin. Since these remodelling processes appeared to 
specifically affect IAPP
+/+
 mice it is possible that postnatal amylin replacement may rescue 
this dynamic refinement. In case of a critical prenatal neurotrophic action of amylin the 
possibility to modulate the development of AP-NTS projections by amylin treatment of the 
mother seem to be limited. It is unclear whether amylin crosses the placenta in sufficient 
amounts to exert an influence on the embryonic brain. Studies characterizing the human ex 
vivo placental transfer of the amylin analogue pramlintide demonstrated a negligible passage 
of this peptide across placental barrier and similar results were obtained for exenatide, a 
synthetic 39 amino acid GLP-1 receptor agonist (Hiles, Bawdon et al. 2003). Provided that 
the placental transfer of amylin is similarly low this observation bears two important 
implications, at least for humans. First, it is unlikely that prenatal amylin treatment of the 
mother directly affects the embryo. Similarly, physiological or pathological changes in 
maternal blood amylin probably also do not influence the developmental process of the 
embryonic brain via a direct impact of maternal amylin. However, amylin is already 
expressed in the foetal period (Rindi, Terenghi et al. 1991; Mulder, Ekelund et al. 1997)
giving rise to a possible neurotrophic action of foetal amylin during prenatal brain 
development.
Our results did not reveal a gender-specific difference in the development of AP-NTS 
projections although there was a tendency towards lower fiber densities in female mice, both 
in IAPP
+/+
 and IAPP
-/-
 animals. Clearly a higher sample size is required to provide further 
support of possible gender-specific differences. Moreover, it has to be taken into 
consideration that the comparison between male and female neuroanatomy may be 
complicated by general gender-specific differences in brain development. Given the 
fundamental role of sex hormones for brain development (Arnold and Gorski 1984; Toran-
Allerand 1984; Rhees, Shryne et al. 1990; Ibanez, Gu et al. 2001; Simerly 2002) such
differences may also exist in the NTS region which has been shown to express receptors for 
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sex steroids (Shughrue, Lane et al. 1997; Haywood, Simonian et al. 1999; Asarian and Geary 
2007). Irrespective of a developmental influence of sex hormones on the formation of AP-
NTS our data clearly point to a similar neurotrophic action of amylin in both male and female 
mice.
Based on the current findings the question arises whether amylin is also important for 
neuronal development in other brain areas and which mechanisms may mediate this action at 
the cellular level. A simple approach to test this may be the comparison of brain weight and 
volume between IAPP
-/-
 and IAPP
+/+
 mice, as it has been investigated for leptin deficient mice 
(Steppan and Swick 1999). If amylin exerted an overall effect on brain development, IAPP
-/-
may show reduced brain weight and volume. Furthermore, amylin replacement might reverse 
this effect. In addition specific DiI tracing studies in other brain sites are required in order to 
confirm a more widespread neurotrophic action of amylin in the CNS. It may be interesting to 
include brain areas with and without known amylin receptor expression.
With regard to the possible mechanism mediating the trophic action of amylin it is reasonable 
to presume that amylin receptors are involved although this assumption awaits furthers 
experimental validation. Interestingly, the caltitonin receptor (CTR), which forms the core 
component of the amylin receptor, is expressed early during ontogeny. Due to its 
spatiotemporal distribution throughout the brain during early embryonic brain development 
the CTR is thought to play a role in neuroblast migration and activation (Tolcos, Tikellis et al. 
2003). In the AP of adult rats a high density of CTR is expressed (Barth, Riediger et al. 2004; 
Becskei, Riediger et al. 2004) together with RAMPs that are necessary for amylin affinity 
(Barth, Riediger et al. 2004). Whether functional amylin receptors mediate amylin’s effect of 
neuronal growth and whether this mediation determines which brain areas are sensitive to 
amylin’s neurotrophic action remains to be clarified.
In conclusion the present study provides convincing evidence that amylin is important
for the development of neuronal projections from the AP to the NTS. Similar to the discovery 
of leptin’s neurotrophic action, this observation strongly suggests a critical function for 
amylin as a developmental signal promoting the maturation of important neural brainstem 
pathways, possibly involved in the control of food intake and fuel homeostasis. Hence, the 
developing brain may be sensitive or even vulnerable to perinatal alterations in amylin levels. 
This supports the emerging opinion that hormonal and metabolic influences during critical 
stages of ontogeny lead to a programming of neuronal circuits with consequences for brain 
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function during adulthood. Impressive evidence for this view came from recent studies 
demonstrating underdeveloped neuronal hypothalamic ARH projections in the offspring of 
diet-induced obese rats (Bouret, Gorski et al. 2008) that in turn is also prone to leptin 
resistance and obesity. Interestingly, such developmental disturbances seem to increase the 
risk for obesity and associated metabolic disorders such as diabetes mellitus later in the life. 
The current study adds further support to this concept of developmental hormonal imprinting 
with amylin being a possible key factor.
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5 Summary
Amylin is a 37 amino acid peptide which is synthesized in pancreatic beta-cells and 
co-secreted with insulin in response to food intake. The best investigated effects of amylin 
include an inhibition of food intake, glucagon secretion and gastric emptying. In vivo studies 
identified the area postrema (AP) of the brainstem as the primary target structure for these 
actions, where amylin exerts excitatory effects. The amylin-induced excitation is transmitted 
via neuronal projections to the nucleus of the solitary tract (NTS), which is an important relay 
center for signals from the AP but which also receives signals directly from the 
gastrointestinal tract via vagal and non-vagal afferents. Apart from its central nervous effects, 
amylin has been shown to act as growth factor in bone cells, pancreatic islets and the kidney 
where amylin leads e.g. to the proliferation of proximal tubule cells. It was the aim of the 
present study to explore whether amylin exerts neurotrophic effects during early brain 
development that may contribute to the growth of neuronal pathways originating in the AP.
Recent studies had shown that the lipostatic and anorectic hormone leptin is essential 
for the postnatal delevopment of neuronal projections from the hypothalamic arcuate nucleus 
to other hypothalamic key structures for the regulation of energy balance. Based on a similar
experimental approach crystals of the lipophilic tracer DiI were implanted into the AP of 
postnatal amylin deficient (IAPP
-/-
) mice and their wildtype littermates (IAPP
+/+
).
In 10 day old neonates the average fiber density in the NTS of IAPP
-/-
mice was
significantly reduced compared to IAPP
+/+
 littermates. There was no obvious gender specific 
difference because a lower NTS fiber density was found in both male and female IAPP
-/-
mice. Interestingly, there seemed to be neuronal remodelling processes between postnatal day 
10 and 14 which were reflected by a decrease in the NTS fiber density of IAPP
+/+
mice during 
this time period. In additional experiments we assessed the plasma amylin levels in neonates 
from postnatal day 6 to 9. At this stage amylin levels were similar to published values 
obtained from adult mice supporting the presumed role of amylin as neurotrophic factor 
during the early brain development.
In conclusion this study provides first evidence for a critical function of amylin as a 
neurotrophic factor affecting the development of important brainstem pathways involved in 
the control of food intake. Therefore the present findings substantiate the concept that the 
developing brain is imprinted by and possibly vulnerable to hormonal influences during the 
perinatal stage. There is cumulative evidence that such processes may have an impact on the 
risk to develop metabolic diseases (e.g. diabetes mellitus) and excessive body weight 
(obesity) later in life.
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6 Zusammenfassung
Amylin ist ein Peptid aus 37 Aminosäuren und wird in den Beta-Zellen des Pankreas 
gebildet, aus denen es zusammen mit Insulin als Antwort auf die Nahrungsaufnahme 
freigesetzt wird. Die am besten untersuchten Effekte von Amylin sind eine Hemmung der 
Nahrungsaufnahme, der Glukagon Sekretion und der Magenentleerung. In vivo Studien
konnten die im Hirnstamm gelegene Area Postrema (AP) als die primäre Zielstruktur 
hinsichtlich dieser Wirkungen identifizieren. Amylin induziert in der AP exzitatorische 
Effekte, die über neuronale Projektionen zum Nucleus tractus solitarii (NTS) übertragen
werden. Dieser stellt eine wichtige Schaltstelle für Signale von der AP dar, erhält aber auch 
direkt Signale aus dem Gastrointestinaltrakt über vagale und nicht vagale Afferenzen. 
Abgesehen von seinen zentralen Effekten wirkt Amylin auch als Wachstumsfakor in 
Knochenzellen, im Pankreas und in der Niere, wo es z.B. die Proliferation von proximalen 
Tubulus Zellen stimuliert. Es war das Ziel der vorliegenden Arbeit zu untersuchen, ob Amylin 
neurotrophische Effekte während der frühen Entwicklung des Gehirns ausübt und somit am 
Wachstum von Nervenbahnen, die aus der AP entspringen, beteiligt ist.
Wie kürzlich gezeigt wurde, ist dass das lipostatische und verzehrsreduzierende 
Hormon Leptin für die postnatale Entwicklung von neuronalen Projektionen, die vom 
Nucleus arcuatus im Hypothalmus ausgehen, essentiell. Die neuronalen Verbindungen 
projizieren zu anderen hypothalamischen Schlüssenstrukturen, welche ihrerseits an der 
Regulation der Nahrungsaufnahme beteiligt sind. Basierend auf einem ähnlichen 
experimentellen Ansatz implantierten wir Kristalle des lipophilen Fluoreszenz-Farbstoffes DiI 
in die AP von postnatalen amylin defizienten Mäusen (IAPP
-/-
) und deren Wildtyp-
Wurfgeschwistern (IAPP
+/+
).
Die durchschnittliche Faserdichte im NTS von neugeborenen 10 Tage alten IAPP
-/-
Mäusen war signifikant reduziert, verglichen mit IAPP
+/+
 Wurfgeschwistern. Dabei gab es 
keinen geschlechtsspezifischen Unterschied, weil sowohl männliche, als auch weibliche
IAPP
-/-
Mäuse eine verminderte Faserdichte im NTS aufwiesen. Interessanterweise scheinen
zwischen dem postnatalem Tag 10 und Tag 14 neuronale Umbau-Prozesse zu existieren,
welche durch eine Verminderung der Faserdichten im NTS von IAPP
+/+
 Mäusen in diesem 
Zeitraum gekennzeichnet waren. In zusätzlichen Experimenten untersuchten wir den Plasma 
Amylin Spiegel in neugeborenen Mäusen vom postnatalen Tag 6 bis Tag 9. In dieser Phase 
waren die Amylin Spiegel bereits ähnlich hoch wie veröffentliche Plasma Werte von adulten 
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während der frühen Entwicklung des Gehirnes.
Zusammenfassend konnte durch die vorliegende Studie erstmals  eine massgebliche
Funktion von Amylin als neurotrophischer Faktor nachgewiesen werden. Demzufolge dürfte
Amylin  an  der  Entwicklung  von  wichtigen  Nervenbahnen  im  Hirnstamm  beteiligt  sein,
welche  an  der  Regulation  der  Nahrungsaufnahme  involviert  sind.  Die  vorliegenden
Ergebnisse untermauern daher ein Konzept, nach dem das sich entwickelnde Gehirn durch
hormonelle Einflüsse im perinatalen Stadium geprägt wird und möglicherweise sensibel auf
hormonelle  Faktoren  reagiert.  Wie  sich  immer  mehr  abzeichnet,  scheint  das  Risiko  zur
Entstehung  von  Stoffwechselkrankheiten  (z.B.  Diabetes  Mellitus)  und  übermäßiges
Körpergewicht (Fettsucht) möglicherweise von solchen Prozessen beeinflusst zu werden.
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